BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 31691002)

  • 1. Socioeconomic Position is Positively Associated with Monoclonal Gammopathy of Undetermined Significance in a Population-based Cohort Study.
    Schmidt B; Debold E; Frank M; Arendt M; Dragano N; Dürig J; Dührsen U; Moebus S; Erbel R; Jöckel KH; Eisele L
    Ann Hematol; 2019 Dec; 98(12):2761-2767. PubMed ID: 31691002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genetic risk score of alleles related to MGUS interacts with socioeconomic position in a population-based cohort.
    Baak L; Frank M; Dürig J; Dührsen U; Hoffmann P; Nöthen MM; Dragano N; Erbel R; Jöckel KH; Schmidt B
    Sci Rep; 2022 Mar; 12(1):4409. PubMed ID: 35292679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.
    Go RS; Gundrum JD; Neuner JM
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):177-186.e4. PubMed ID: 25445471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study.
    Chang SH; Luo S; O'Brian KK; Thomas TS; Colditz GA; Carlsson NP; Carson KR
    Lancet Haematol; 2015 Jan; 2(1):e30-6. PubMed ID: 26034780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
    Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
    JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study.
    Landgren O; Shim YK; Michalek J; Costello R; Burton D; Ketchum N; Calvo KR; Caporaso N; Raveche E; Middleton D; Marti G; Vogt RF
    JAMA Oncol; 2015 Nov; 1(8):1061-8. PubMed ID: 26335650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is long-term particulate matter and nitrogen dioxide air pollution associated with incident monoclonal gammopathy of undetermined significance (MGUS)? An analysis of the Heinz Nixdorf Recall study.
    Orban E; Arendt M; Hennig F; Lucht S; Eisele L; Jakobs H; Dürig J; Hoffmann B; Jöckel KH; Moebus S
    Environ Int; 2017 Nov; 108():237-245. PubMed ID: 28886417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D and monoclonal gammopathy of undetermined significance (MGUS) among U.S. Black women.
    Ruiz Lopez JN; McNeil GE; Zirpoli G; Palmer JR; Kataria Y; Bertrand KA
    Cancer Causes Control; 2024 Feb; 35(2):277-279. PubMed ID: 37707565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of monoclonal gammopathy of undetermined significance in an elderly urban Korean population.
    Park HK; Lee KR; Kim YJ; Cho HI; Eun Kim J; Woong Kim K; Jung Kim Y; Lee KW; Hyun Kim J; Bang SM; Lee JS
    Am J Hematol; 2011 Sep; 86(9):752-5. PubMed ID: 21786289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal gammopathy of undetermined significance is associated with prostate cancer in a population-based cohort study.
    Hornung N; Frank M; Dragano N; Dürig J; Dührsen U; Moebus S; Erbel R; Stang A; Jöckel KH; Schmidt B
    Sci Rep; 2021 Sep; 11(1):19266. PubMed ID: 34588555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
    El-Khoury H; Lee DJ; Alberge JB; Redd R; Cea-Curry CJ; Perry J; Barr H; Murphy C; Sakrikar D; Barnidge D; Bustoros M; Leblebjian H; Cowan A; Davis MI; Amstutz J; Boehner CJ; Lightbody ED; Sklavenitis-Pistofidis R; Perkins MC; Harding S; Mo CC; Kapoor P; Mikhael J; Borrello IM; Fonseca R; Weiss ST; Karlson E; Trippa L; Rebbeck TR; Getz G; Marinac CR; Ghobrial IM
    Lancet Haematol; 2022 May; 9(5):e340-e349. PubMed ID: 35344689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for monoclonal gammopathy of undetermined significance: a systematic review.
    Castaneda-Avila MA; Ulbricht CM; Epstein MM
    Ann Hematol; 2021 Apr; 100(4):855-863. PubMed ID: 33416902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and the Transformation of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma: A Population-Based Cohort Study.
    Chang SH; Luo S; Thomas TS; O'Brian KK; Colditz GA; Carlsson NP; Carson KR
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Monoclonal Gammopathy of Undetermined Significance in India-A Hospital-based Study.
    Gupta R; Dahiya M; Kumar L; Shekhar V; Sharma A; Ramakrishnan L; Sharma OD; Begum A
    Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):e345-e350. PubMed ID: 29980412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A; Czarkowska-Paczek B
    Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
    Chang SH; Gumbel J; Luo S; Thomas TS; Sanfilippo KM; Luo J; Colditz GA; Carson KR
    Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2055-2061. PubMed ID: 31501149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifetime Pesticide Use and Monoclonal Gammopathy of Undetermined Significance in a Prospective Cohort of Male Farmers.
    Hofmann JN; Beane Freeman LE; Murata K; Andreotti G; Shearer JJ; Thoren K; Ramanathan L; Parks CG; Koutros S; Lerro CC; Liu D; Rothman N; Lynch CF; Graubard BI; Sandler DP; Alavanja MC; Landgren O
    Environ Health Perspect; 2021 Jan; 129(1):17003. PubMed ID: 33404262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota.
    Kleinstern G; Larson DR; Allmer C; Norman AD; Muntifering G; Sinnwell J; Visram A; Rajkumar V; Dispenzieri A; Kyle RA; Slager SL; Kumar S; Vachon CM
    Blood Cancer J; 2022 Apr; 12(4):67. PubMed ID: 35440099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of risk factors for monoclonal gammopathy of undetermined significance.
    Boursi B; Weiss BM; Haynes K; Mamtani R; Yang YX
    Am J Hematol; 2016 Jun; 91(6):581-4. PubMed ID: 26953904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.